Preliminary Efficacy and Safety Results of TQB3473, a Novel Syk Inhibitor, in Adult Patients with Immune Thrombocytopenia (ITP)
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Hu Zhou, Bingjie Ding, Tiejun Gong, Xiangzhou Du, Xiaoming Li, Yinghui Lai, Zhenyu Yan, Rong Fu, Xin Du, Qian Zhao
Institutions: Zhengzhou University, Henan Cancer Hospital, Shenzhen University, Ganzhou People's Hospital, Shenzhen Second People's Hospital, Affiliated Hospital of Southwest Medical University, Guangxi Medical University, North China University of Science and Technology, North China University of Science and Technology Affiliated Hospital, Tianjin Medical University General Hospital, Tianjin Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405043365